Cost-effectiveness assessments important for HIV response in Africa

May 09, 2002

A systematic review in this week's issue of THE LANCET highlights the importance of cost-effectiveness evaluation to identify realistic intervention programmes to tackle HIV/AIDS in Africa.

HIV/AIDS accounts for around 20% of all deaths in Africa. The cost-effectiveness of interventions is important as African governments face difficult choices in striking the right balance between prevention, treatment, and care, all of which are necessary to deal with the HIV/AIDS epidemic. Andrew Creese from WHO, Geneva, Switzerland, and colleagues assessed existing data and their implications for value-for-money strategies to combat HIV/AIDS in Africa.

The investigators identified over 60 reports that measured cost and effectiveness of HIV/AIDS interventions. 24 studies were used to calculate standardised estimates of cost (US$) per HIV infection prevented and cost per disability-adjusted life-year (DALY) gained for 31 interventions.

Cost-effectiveness varied greatly between interventions. A case of HIV/AIDS could be prevented for $11, and a DALY gained for $1, by selective blood safety measures, and by targeted condom distribution with treatment of sexually transmitted diseases. Single-dose nevirapine and short-course zidovudine for prevention of mother-to-child transmission, voluntary counselling and testing, and tuberculosis treatment cost under $75 per DALY gained. Other interventions (eg. formula feeding for infants, home care programmes, and antiretroviral therapy for adults) cost several thousand dollars per infection prevented, or several hundreds of dollars per DALY gained.

Andrew Creese comments: "Allocation of new funds for HIV/AIDS requires more than rankings of cost-effectiveness. Nevertheless, value for money is important, especially in African countries, where resources are particularly scarce and needs are so great. Existing cost-effectiveness data are few, and much more high quality research is needed for detailed planning and programming. Yet even the available data make it clear that a spending programme for HIV/AIDS relief in Africa that neglects to bring cost-effectiveness evidence into the consultation process risks unnecessary sacrifice of hundreds of thousands of prevention opportunities, treatment opportunities, and lives."

A research letter (p 1667) in this week's issue of THE LANCET describes the potential of a low-cost drug combination for people with HIV-1 infection. Nicholas Paton and colleagues from Tan Tock Seng Hospital, Singapore, gave 22 individuals with HIV-1 a combination of the drugs hydroxychloroquine, hydroxycarbamide, and didanosine taken twice daily for just under a year. The treatment produced a sustained reduction in viral load and the CD4 cell count was maintained. The investigators conclude that this new combination of drugs could be suitable for countries that have restricted resources.
-end-
Contact: Mr Andrew Creese, Essential Drugs and Medicines Policy Department, WHO, 1211 Geneva 27, Switzerland; T) +41 22 791 2570; F) +41 22 791 4167; E) creesea@who.int

Dr Nicholas I Paton, Department of Infectious Diseases, Communicable Disease Centre, Tan Tock Seng Hospital, Moulmein Road, 308433, Singapore; T) +65 6357 7924/5; F) +65 6252 4056; E) Paton_NIJ@ttsh.com.sg

Lancet

Related Infection Articles from Brightsurf:

Halving the risk of infection following surgery
New analysis by the University of Leeds and the University of Bern of more than 14,000 operations has found that using alcoholic chlorhexidine gluconate (CHG) halves the risk of infection in certain types of surgery when compared to the more commonly used povidone-iodine (PVI).

How plants shut the door on infection
A new study by an international team including University of Maryland scientists has discovered the key calcium channel responsible for closing plant pores as an immune response to pathogen exposure.

Sensing infection, suppressing regeneration
UIC researchers describe an enzyme that blocks the ability of blood vessel cells to self-heal.

Boost to lung immunity following infection
The strength of the immune system in response to respiratory infections is constantly changing, depending on the history of previous, unrelated infections, according to new research from the Crick.

Is infection after surgery associated with increased long-term risk of infection, death?
Whether experiencing an infection within the first 30 days after surgery is associated with an increased risk of another infection and death within one year was the focus of this observational study that included about 660,000 veterans who underwent major surgery.

Revealed: How E. coli knows how to cause the worst possible infection
The discovery could one day let doctors prevent the infection by allowing E. coli to pass harmlessly through the body.

UK study shows most patients with suspected urinary tract infection and treated with antibiotics actually lack evidence of this infection
New research presented at this week's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Amsterdam, Netherlands (April 13-16, 2019) shows that only one third of patients that enter the emergency department with suspected urinary tract infection (UTI) actually have evidence of this infection, yet almost all are treated with antibiotics, unnecessarily driving the emergence of antimicrobial resistance.

Bacteria in urine doesn't always indicate infection
Doctors should think carefully before testing patients for a urinary tract infection (UTI) to avoid over-diagnosis and unnecessary antibiotic treatment, according to updated asymptomatic bacteriuria (ASB) guidelines released by the Infectious Diseases Society of America (IDSA) and published in Clinical Infectious Diseases.

Subsidies for infection control to healthcare institutions help reduce infection levels
Researchers compared three types of infection control subsidies and found that under a limited budget, a dollar-for-dollar matching subsidy, in which policymakers match hospital spending for infection control measures, was the most effective at reducing the number of hospital-acquired infections.

Dengue virus infection may cause severe outcomes following Zika virus infection during pregnancy
This study is the first to report a possible mechanism for the enhancement of Zika virus progression during pregnancy in an animal model.

Read More: Infection News and Infection Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.